Skip to main content
Premium Trial:

Request an Annual Quote

Stéphane Bancel, Harry Wilcox

BG Medicine announced Stéphane Bancel has resigned from its board and has been replaced by Harry Wilcox. Bancel and Wilcox are affiliated with Flagship Ventures, a shareholder in BG Medicine. Wilcox has been COO and general partner at Flagship since 2013. Before that, he was CFO and a partner at the venture capital firm. Prior to joining Flagship, he served as CFO and senior vice president of corporate development at Exact Sciences. 

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.